Perastine

Perastine

SCHEMBL1506306

c1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.83
CYP1A2 P05177 2/20 0.83
CYP2D6 P10635 2/20 0.83
TSHR P16473 2/20 0.83
CYP2C19 P33261 2/20 0.83
HIF1A Q16665 2/20 0.83
SLC6A2 P23975 2/20 0.83
SLC6A4 P31645 2/20 0.83
SLC6A3 Q01959 2/20 0.83
SLC22A1 O15245 1/20 0.83
CHRM2 P08172 1/20 0.83
HTR1A P08908 1/20 0.83
ADRA2A P08913 1/20 0.83
CHRM1 P11229 1/20 0.83
DRD1 P21728 1/20 0.83
TBXA2R P21731 1/20 0.83
ADRA1A P35348 1/20 0.83
OPRM1 P35372 1/20 0.83
DRD3 P35462 1/20 0.83
KCNH2 Q12809 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perastine SCHEMBL29768269 0.98 CYP3A4 (0.83) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL10357800 0.93 SIGMAR1 (0.81) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
Cloperastine SCHEMBL29617329 0.91 SLC6A2 (1.00) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
Cloperastine SCHEMBL9613613 0.91 SLC6A2 (1.00) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL17942915 0.91 CYP3A4 (0.75) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
Cloperastine SCHEMBL284715 0.91 SLC6A2 (1.00) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
Cloperastine SCHEMBL23733 0.90 CYP3A4 (1.00) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL1151981 0.89 SLC6A2 (0.97) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
Cloperastine SCHEMBL1651228 0.89 SLC6A2 (0.95) CYP3A4CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL10357706 0.86 SIGMAR1 (0.77) CYP3A4CYP1A2CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
EP-0259227-B1 BENZHYDRYLOXYETHYL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Société anonyme: LES LABORATOIRES MERAM (FR) 1991-12-27 EP claimed
US-4983614-A ANTISPASMODIC, ANTIALLERGENIC AND ANTIHISTAMINE AGENTS LES LABORATOIRES MERAM (FR) 1991-01-08 US claimed
EP-0259227-A1 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them Société anonyme: LES LABORATOIRES MERAM (FR) 1988-03-09 EP claimed
EP-4746966-A1 4-AMINO-2,6-BIS(PHENYLMETHYLENE)CYCLOHEXANONES AND THEIR USE Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) 2026-05-27 EP disclosed
WO-2025130120-A1 USE OF MANGIFERIN IN PREPARING FERROPTOSIS INHIBITOR 浙江省中医药研究院 2025-06-26 WO disclosed
CN-118806777-B Application of stachyose in preparing medicine for preventing and relieving myocardial ischemia reperfusion injury 无锡市第二人民医院 2025-03-18 CN disclosed
WO-2025021236-A1 4-AMINO-2,6-BIS(PHENYLMETHYLENE)CYCLOHEXANONES AND THEIR USE Ustav Organicke Chemie A Biochemie AV CR v.v.i. (CZ) 2025-01-30 WO disclosed
CN-118806777-A Application of stachyose in preparing medicine for preventing and relieving myocardial ischemia reperfusion injury 无锡市第二人民医院 2024-10-22 CN disclosed
CN-116270595-B Application of biflavone compound in preparation of medicine for inhibiting neuronal cell iron death 中国人民解放军军事科学院军事医学研究院 2024-09-27 CN disclosed
US-4983614-A ANTISPASMODIC, ANTIALLERGENIC AND ANTIHISTAMINE AGENTS LES LABORATOIRES MERAM (FR) 1991-01-08 US disclosed
US-4983614-A ANTISPASMODIC, ANTIALLERGENIC AND ANTIHISTAMINE AGENTS LES LABORATOIRES MERAM (FR) 1991-01-08 US disclosed
US-4983614-A ANTISPASMODIC, ANTIALLERGENIC AND ANTIHISTAMINE AGENTS LES LABORATOIRES MERAM (FR) 1991-01-08 US disclosed
EP-0259227-A1 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them Société anonyme: LES LABORATOIRES MERAM (FR) 1988-03-09 EP disclosed
EP-0259227-A1 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them Société anonyme: LES LABORATOIRES MERAM (FR) 1988-03-09 EP disclosed
EP-0259227-A1 Benzhydryloxyethyl piperidine derivatives, process for their preparation and pharmaceutical compositions containing them Société anonyme: LES LABORATOIRES MERAM (FR) 1988-03-09 EP disclosed